BrainStorm Issues 2018 Letter to Shareholders
NEW YORK, Dec. 27, 2018 (GLOBE NEWSWIRE) — BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell […]
VIVUS to Present at Biotech Showcase on January 9, 2019
CAMPBELL, Calif., Dec. 27, 2018 (GLOBE NEWSWIRE) — VIVUS, Inc. (Nasdaq: VVUS) (the “Company”), a specialty pharmaceutical company committed to […]
Primoris Services Corporation Announces Electrical T&D Award Valued Over $28 Million
DALLAS, Dec. 27, 2018 (GLOBE NEWSWIRE) — Primoris Services Corporation (NASDAQ Global Select: PRIM) (“Primoris” or “Company”) today announced a […]
BeyondSpring Announces Positive Pre-NDA Meeting with the U.S. FDA for its Lead Asset, Plinabulin
Company On Track to Submit New Drug Applications for Non-Small Cell Lung Cancer and Chemotherapy-Induced Neutropenia in the United States […]
Revival Gold 2018 Year in Review
TORONTO, Dec. 27, 2018 (GLOBE NEWSWIRE) — Revival Gold Inc. (TSXV: RVG, OTCQB: RVLGF) (“Revival Gold” or the “Company”), a […]
Myriad Genetics to Present at the 37th Annual J.P. Morgan Healthcare Conference
SALT LAKE CITY, Dec. 27, 2018 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN) announced today that Mark C. Capone, […]
G1 Therapeutics to Present at 37th Annual J.P. Morgan Healthcare Conference
RESEARCH TRIANGLE PARK, N.C., Dec. 27, 2018 (GLOBE NEWSWIRE) — G1 Therapeutics, Inc. (Nasdaq: GTHX), a clinical-stage oncology company, today […]
Cyclacel Pharmaceuticals to Present at Biotech Showcase™ 2019 in San Francisco
BERKELEY HEIGHTS, N.J., Dec. 27, 2018 (GLOBE NEWSWIRE) — Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC, Nasdaq:CYCCP) (“Cyclacel” or the “Company”), a [...]
Axsome Therapeutics Provides Year End 2018 Clinical Update
FDA clearance of IND received for Phase 2 trial of AXS-12 in narcolepsy Phase 2 results of AXS-05 in major […]
Osmotica Pharmaceuticals Appoints Seasoned Financial Executive Gregory Cowan to Board of Directors and Audit Committee
BRIDGEWATER, N.J., Dec. 27, 2018 (GLOBE NEWSWIRE) — Osmotica Pharmaceuticals plc (“Osmotica” or the “Company”) (Nasdaq: OSMT), a fully integrated […]
